Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 14, 2008. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by five individuals (Mr. R M Bondy, Mr. E J Gray, Mr. J S Heslop, Mr. D Learmouth, and Mr. A P Witty) on January 10, 2008. Each individual acquired 9 shares through the personal contribution element and 9 shares through the company matching element of the ShareReward Plan. The transaction price was GBP 13.90 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the specific share transactions mentioned above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: January 10, 2008.
- Share Price: GBP 13.90 per Ordinary share.
- Participants: Five senior executives acquired shares via the ShareReward Plan.
- Volume: Each participant acquired a total of 18 shares (9 personal, 9 company match).
- Notification Date: The company and participants were advised on January 11, 2008.